Core Alternative Capital Abbott Laboratories Transaction History

Core Alternative Capital

$448 Million
Q4 2024

A detailed history of Core Alternative Capital transactions in Abbott Laboratories stock. As of the latest transaction made, Core Alternative Capital holds 603 shares of ABT stock, worth $77,141. This represents 0.02% of its overall portfolio holdings.

Number of Shares

603

Previous 556 8.45%

Holding current value

$77,141

Previous $63,000 7.94%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	BUY	$111.93 - $119.39 $5,260 - $5,611	47 Added 8.45%	603 $68,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $71,954 - $79,470	-657 Reduced 54.16%	556 $63,000
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $11,363 - $13,910	-126 Reduced 9.41%	1,213 $133,000
Q3 2023 Oct 19, 2023	BUY	$95.53 - $114.62 $4,680 - $5,616	49 Added 3.8%	1,339 $129,000
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $27,613 - $30,767	274 Added 26.97%	1,290 $140,000
Q1 2023 Apr 18, 2023	BUY	$96.86 - $114.01 $36,419 - $42,867	376 Added 58.75%	1,016 $102,000
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $92,303 - $108,285	-971 Reduced 60.27%	640 $70,000
Q3 2022 Oct 18, 2022	SELL	$96.76 - $112.03 $44,025 - $50,973	-455 Reduced 22.02%	1,611 $156,000
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $13,779 - $16,654	135 Added 6.99%	2,066 $224,000
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $2.74 Million - $3.34 Million	-24,027 Reduced 92.56%	1,931 $229,000
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $448,140 - $548,723	-3,879 Reduced 13.0%	25,958 $3.65 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $139,175 - $153,968	-1,193 Reduced 3.84%	29,837 $3.53 Million
Q2 2021 Aug 05, 2021	BUY	$105.79 - $124.53 $871,286 - $1.03 Million	8,236 Added 36.13%	31,030 $3.6 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $1.87 Million - $2.2 Million	-17,136 Reduced 42.92%	22,794 $2.73 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $1.37 Million - $1.49 Million	-13,032 Reduced 24.61%	39,930 $4.37 Million
Q3 2020 Oct 09, 2020	SELL	$91.64 - $111.29 $901,737 - $1.1 Million	-9,840 Reduced 15.67%	52,962 $5.76 Million
Q2 2020 Jul 13, 2020	SELL	$76.57 - $98.0 $212,098 - $271,460	-2,770 Reduced 4.22%	62,802 $5.74 Million
Q1 2020 Jun 09, 2020	BUY	$62.82 - $91.86 $2.43 Million - $3.55 Million	38,655 Added 143.61%	65,572 $5.17 Million
Q4 2019 Jun 05, 2020	BUY	$78.51 - $87.4 $2.11 Million - $2.35 Million	26,917 New	26,917 $2.34 Million

Others Institutions Holding ABT

# of Institutions

3,217

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.

Account

Core Alternative Capital Abbott Laboratories Transaction History